e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Community acquired pneumonia - epidemiology and host defence
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The antimicrobial molecule elafin protects the lung against
Staphylococcus aureus
infection
J. McMichael, A. Maxwell, K. Hayashi, K. Taylor, J. Dorin, J. M. Sallenave (Edinburgh, United Kingdom)
Source:
Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Session:
Community acquired pneumonia - epidemiology and host defence
Session type:
Oral Presentation
Number:
186
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. McMichael, A. Maxwell, K. Hayashi, K. Taylor, J. Dorin, J. M. Sallenave (Edinburgh, United Kingdom). The antimicrobial molecule elafin protects the lung against
Staphylococcus aureus
infection. Eur Respir J 2004; 24: Suppl. 48, 186
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Mechanisms of acquisition of resistance in
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection
Source: Eur Respir J 2002; 20: Suppl. 38, 357s
Year: 2002
Human airway epithelial cell response to
Pseudomonas aeruginosa
virulence factors preceded or not by
Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Staphlococcus aureus
: susceptibility to antibacterial drugs and rate of MRSA
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006
Time-dependent response of airway epithelial cells to
Staphylococcus aureus
Source: Eur Respir J 2004; 24: Suppl. 48, 555s
Year: 2004
Treatment challenges in methicillin resistant
Staphylococcus aureus
infections
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Source: Eur Respir J 2010; 36: 901-906
Year: 2010
Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase
Source: Eur Respir J 2002; 19: 1136-1141
Year: 2002
Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol.
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia
Source: Eur Respir J 2013; 41: 935-942
Year: 2013
Prevalence and impact on FEV
1
decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Staphylococcus aureus sensitivity changes to antibiotics under the influence of dissolved ozone
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Cell wall deficiency: a novel mechanism for methicillin resistance in
Staphylococcus aureus
Source: Eur Respir J 2005; 26: Suppl. 49, 94s
Year: 2005
Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
Significance of methicillin-resistant
staphylococcus aureus
in lower respiratory tract infections
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept